This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Philip Edwin Pinder
Introduction
Philip Edwin Pinder is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medical diagnostics, particularly in the measurement of plasminogen activators. His work has implications for therapeutic applications and the development of diagnostic kits.
Latest Patents
Pinder holds a patent for an assay method that measures the activity of plasminogen activators, such as urokinase plasminogen activator (uPA) and tissue plasminogen activator (tPA). This innovative method includes the use of an elastase inhibitor in the assay mixture, enhancing the accuracy of the measurements. The patent also encompasses a diagnostic kit for measuring plasminogen activators and a method for determining the effective therapeutic dose of a plasminogen activator inhibitor. Additionally, it provides a method for preparing a pharmaceutical composition. Pinder has 1 patent to his name.
Career Highlights
Philip Edwin Pinder is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions in the medical field. His expertise in assay methods has contributed to advancements in diagnostics and therapeutic strategies.
Collaborations
Pinder has collaborated with Paul Elvin, enhancing the research and development efforts in their projects. Their partnership has fostered innovation and has been instrumental in the success of their endeavors.
Conclusion
Philip Edwin Pinder's contributions to the field of medical diagnostics through his innovative assay method highlight his role as a significant inventor. His work continues to impact the development of diagnostic tools and therapeutic applications.